QuickView for toll-like receptor TLR6:TLR2 signaling pathway (biogroup)

1. Cerebral organoids with CRISPR-Cas9 induced APOE E3E3 allele expression
2. Dermal macrophages, epidermal Langerham Cells and CD14+ cells subsets
3. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens

There were no matches for toll-like receptor TLR6:TLR2 signaling pathway

There were no clinical trials for toll-like receptor TLR6:TLR2 signaling pathway